Initial Experience of Contact Laser Vaporization of the Prostate (CVP) for Benign Prostate Hyperplasia Patients With Hemorrhagic Risk
Conclusion: CVP treatment appears to be acceptable for BPH patients with hemorrhagic risk. In this study, late-onset hemorrhage occurred approximately 1 month postoperatively. Close postoperative follow-up is required.
Saved in:
| Main Authors: | Yushi Araki, Takashi Kawahara, Teppei Takeshima, Kazuhide Makiyama, Hiroji Uemura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Advances in Urology |
| Online Access: | http://dx.doi.org/10.1155/aiu/6108816 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of rapidly progressive prostate cancer with bone and lymph node metastasis after contact laser vaporization for benign prostatic hyperplasia
by: Kei Muraoka, et al.
Published: (2025-01-01) -
Benign prostatic hyperplasia and periodontitis
by: YANG Shisong, et al.
Published: (2024-03-01) -
Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2020-06-01) -
Clinical pathway interpretation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia
by: Si-Yu YAN, et al.
Published: (2022-06-01) -
The effect of systemic hypertension on prostatic arterial hemodynamics in dogs with benign prostate hyperplasia
by: Çağatay ESİN
Published: (2024-11-01)